Antibiotic Stewardship at Hospital Discharge (CE Session)
Description:
Date/Time: April 10, 2024 | 1:05 - 1:45 ET
In this session, vital strategies to optimize antibiotic use post-hospitalization will be explored. Antibiotic stewardship is imperative in healthcare, and this session will provide critical principles guiding this practice. The complexities surrounding antibiotic overuse at discharge will be discussed, providing a comprehensive summary of existing knowledge in this area. Understanding these nuances is crucial in identifying opportunities for improvement and implementing effective discharge antibiotic stewardship interventions.
By the end of this presentation, attendees will gain a deeper understanding of antibiotic stewardship principles, be equipped to summarize the landscape of antibiotic overuse at discharge, and have the ability to identify key strategies for enhancing antibiotic use post-hospitalization.
Learning Objectives:
At the end of this session, the learner should be able to:
- Review principles of antibiotic stewardship;
- Summarize what is known about antibiotic overuse at discharge;
- Identify opportunities to improve antibiotic use at discharge and key discharge antibiotic stewardship interventions.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Emily Sydnor Spivak, MD, MHS, FIDSA, FSHEA
Associate Professor of Medicine, Division of Infectious Diseases
University of Utah School of Medicine
Emily Spivak, MD, MHS, FIDSA, FSHEA, is an Associate Professor of Medicine in the Division of Infectious Diseases at the University of Utah School of Medicine. She established and serves as Co-Director of the Antimicrobial Stewardship Programs at University of Utah Health and the Salt Lake City Veterans Affairs Healthcare System. She completed her residency and fellowship training at the Johns Hopkins University School of Medicine and earned a Masters in Health Sciences in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health.
Dr. Spivak's research interests focus on understanding patterns and drivers of antimicrobial use, methods to assess appropriateness, and development and evaluation of methods to improve antimicrobial use. She has led clinical research focused on evaluating patient outcomes related to various antibiotic use strategies.
She is a member and fellow of the Society of Healthcare Epidemiology (SHEA) and the Infectious Diseases Society of America (IDSA). She also serves as a Board of Scientific Counselors to the Office of Infectious Diseases at the Centers for Disease Control and Prevention (CDC).